The Syneos Health Podcast

The Syneos Health Podcast
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Hosted by Jeff Stewart, …

Medical Affairs Series, Part Three: Moving to the Left
Nov 6 • 12 min
Traditionally, Medical Affairs has served as a support function in later phases of product development, but they now need to play a more strategic and value-based role within the organization – and that means earlier and deeper engagement.In …
Advocacy Archetypes
Oct 24 • 32 min
Patients have been at the forefront of many of healthcare’s most historic moments—not just as subjects, but also as catalysts for change. Some of today’s advocates look to the early ACT UP years for inspiration; others turn to blueprints established…
Medical Affairs Series, Part Two - Measuring the Unmeasurable: Medical Affairs Metrics
Oct 9 • 14 min
No industry standard currently exists to measure value and impact of medical affairs, and the traditional metrics that companies often use to determine return on investment (ROI) simply don’t apply.In this second episode in our Medical Affair…
Why We Resist
Sep 25 • 20 min
Why do people make good (and bad) decisions about their health? How can we help motivate them to change and give them the resilience to try and try again? Our industry and our world are obsessed with those questions right now.
Medical Affairs Series, Part One: A Foundation for Medical Affairs
Sep 11 • 10 min
Medical Affairs, once considered a support function, now has a seat at the table as one of the major pillars of biopharmaceutical organizations. So now what? Our new Medical Affairs series, which will unfold over the next several months,…
A Regulatory Roadmap for Real World Evidence
Aug 28 • 19 min
The need for real world evidence is growing beyond its original footprint of post-market intelligence, with uses now including regulatory approval, proof of value, maximized access and more. However, without a true understanding of the regulat…
Talented Teams
Aug 14 • 19 min
Creating and supporting productive, motivated and happy teams is an ongoing challenge in today’s global workplace – and particularly in the fast-paced biopharmaceutical marketplace. Incentives can differ based on region, culture, or individual…
Digital Therapeutics
Jul 31 • 19 min
There are dozens of software-driven products under regulatory review for diagnosing, treating, or preventing medical conditions, defining an entirely new sector for the life sciences industry.Today we are joined by
Talking About PIE
Jul 17 • 23 min
Not that kind of pie. In this case, PIE – or Preapproval Information Exchange – refers to the communication of clinical and health care economic information on therapies in development between U.S. population health decision makers an…
MOAs in ONC: The Latest and Greatest in the Oncology Pipeline
Jul 3 • 14 min
Oncology continues to be one of the hottest therapeutic areas in the biopharmaceutical industry, but one that also poses some of the greatest challenges to developers.
037: Psychology in Clinical Trials
Jun 19 • 9 min
When it comes to clinical trials, what do clinical psychologists bring to the table?Quite a lot, says Alexandria Wise-Rankovic, Ph.D., a clinical psychologist and Senior Vice Pres…
036: Commercialization for Emerging Companies
Jun 5 • 8 min
The biopharmaceutical market has evolved quite a bit over the last five to 10 years. As more emerging companies are opting to commercialize on their own, they can no longer look to the “tried and true,” traditional strategies for bringing a th…
035: How Translational Science Can Solve Pharma’s Productivity Puzzle
May 15 • 12 min
The infrastructure we rely on to create new medicines is in sore need of an upgrade. More and more investigational drugs are streaming into the pipeline. But most of them fail in clinical trials, draining corporate resources, disappointing investors…
034: Can the Gut Microbiome Revolutionize Medical Care?
May 1 • 22 min
Research in the area of live biotherapeutics has exploded in the last seven years. There is still much to learn about whether a dysregulated gut microbiome (dysbiosis) causes disease, or whether disease leads to dysbiosis – but the potential for sig…
APAC Edition: Medical Affairs in China
Apr 26 • 9 min
The role of Medical Affairs has changed dramatically in China over the last 10-15 years, moving from what was once considered a secondary support function to one now at the forefront of a more patient-centric paradigm.Sam Ying, Vice President…
033: From DTC to DT”Me” - The Future of Communications in Pharmaceuticals
Apr 17 • 10 min
The art of communications in the pharmaceutical industry is becoming more complex.According to Amy Hutnik, Chief Growth and Transformation Officer for
032: Navigating the New EU Medical Device Regulations
Apr 3 • 12 min
New regulations, which were adopted on May 26, 2017, will affect all device and diagnostics manufacturers looking to sell products in the EU, with stricter requirements being introduced in order for these products to be approved. We are just o…
APAC Edition: Acceleration in Asia
Mar 29 • 16 min
In this first episode of the Syneos Health Podcast: APAC Edition, host Robbie Chana speaks with Sebastian Bather, President of…
031: Real World Evidence in Europe
Mar 20 • 13 min
According to the Syneos Health 2019 Health Trend Ten, perhaps the biggest shift for 2019 and beyond is global focus on understanding what product differentiation looks like in real-world …
030: Land of Opportunity: R&D in Asia Pacific
Mar 6 • 10 min
Big changes are happening in Asia, opening up a world of possibilities for biopharmaceutical companies to accelerate clinical development of innovative medicines.Robbie Chana, Vi…
029: Commercial Models of the (Very Near) Future
Feb 20 • 16 min
A commercial model built to deliver blockbuster drugs to the market is no longer effective – particularly for delivering therapies for complex disease states to smaller, more targeted patient populations and specialty providers. But what will …
028: World Cancer Day
Feb 1 • 31 min
The treatment of cancer has undergone a sea change in the span of a generation. In this two-part episode for World Cancer Day, we discuss the increasingly complex oncology landscape, from both a cl…
027: Caregivers
Dec 11, 2018 • 21 min
It’s just one word. But it carries the weight of over 43 million people, about a quarter which spends 41 hours or more per week providing care for loved ones with medical conditions. Caregivers are not just influencers fo…
025: The Health Trend Ten - Commercial Perspective
Nov 27, 2018 • 29 min
As we head toward the close of the year, we are already looking to see what 2019 has in store. Drawing on the knowledge and experience of more than 200 leaders and experts who work on the front lines of healthcare, we identified 10 critical sh…
026: The Health Trend Ten - Clinical Perspective
Nov 27, 2018 • 32 min
As we head toward the close of the year, we are already looking to see what 2019 has in store. Drawing on the knowledge and experience of more than 200 leaders and experts who work on the front lines of healthcare, we identified 10 critical sh…
024: Content that Clicks
Oct 31, 2018 • 25 min
In our increasingly digital world, it was only a matter of time before search and social marketing would start to take on an important role in clinical trial patient recruitment. But with
023: The Clinical Trial Marathon, at a Sprint
Oct 3, 2018 • 21 min
Clinical trials are arguably the largest investment a biopharma company makes in bringing a product to market - in dollars, and time. Driving the stakes higher: the patient is waiting. How can we improve the process, realize shorter and more efficie…
022: Spending for Launch Success
Sep 19, 2018 • 15 min
When it comes to investing in the launch of your biopharma product, how much is too much? Is there such a thing as too little? Director Sachin Purwar and his colleagues from the …
021: The Sales Force Training (R)evolution
Sep 5, 2018 • 14 min
Biopharmaceutical sales forces have changed dramatically over the past decade. And not just the sales forces - the industry, customers, technology and more have all undergone tremendous evolution. As a result,
020: A Syneos Health Short - 21st Century Cures
Jul 9, 2018 • 8 min
The 21st Century Cures Act was passed at the end of 2016 in an effort to accelerate the discovery, development and deliver…
019: A Decade of Dealmakers’ Intentions
Jun 8, 2018 • 16 min
The last decade has seen both depressing lows and astounding highs in biopharmaceutical dealmaking activity. Different therapeutic areas have fallen in and out of favor along with the pace of innovation and there has been a sustained focus on the ne…
018: Partnering with a CRO
May 23, 2018 • 15 min
A relationship with a Contract Research Organization (CRO) is just like any other - to succeed, it requires communication, alignment on goals, respect, and ultimately, trust between two partners. In this episode,
016: Payer Power, Part 2
Apr 25, 2018 • 25 min
Eighteen months is an eternity in the payer world. Previously on The Syneos Health Podcast (Episode 003: Payer Power), we discussed the payer’s rise in influence in the pharmaceutical industry. Today, we’re seeing the impact of strategies pa…
015: ICER - Friend or Foe?
Mar 14, 2018 • 27 min
ICER - the Institute for Clinical and Economic Review - was established as an independent organization to examine the value of pharmaceuticals across disease categories. “But value is in the eye of the beholder,” says
014: MA-“Squared”: Medical Affairs Meets Market Access
Mar 7, 2018 • 20 min
In Episode 012: Medical Affairs from Zero, Suma Ramadas talked about the inception and growing value of the Medical Affairs function. Today, in part two of ou…
009: Rare Diseases
Feb 26, 2018 • 25 min
While regulatory changes have made the path to approval easier for rare disease therapies, it is by no means easy - and
013: Artificial Intelligence for Authentic Engagement
Feb 13, 2018 • 41 min
Since Stanley Kubrick’s 2001: A Space Odyssey introduced the prospect of Artificial Intelligence (AI) with the spaceship computer system HAL, the world has had a rollercoaster relationship with the idea - from hope to hype, and everywhere in between…
012: Medical Affairs from Zero
Feb 6, 2018 • 15 min
Imagine two products that are very similar. One became one of the most successful launches the organization ever had; the other one was a flop. The main difference between the two? Medical Affairs. There was a time - not all that long ago - …
011: Naming, Part 2 - The Drug
Jan 8, 2018 • 23 min
As we learned in our previous episode, naming a company is not …
010: Naming, Part 1 - The Pharma Company
Jan 8, 2018 • 23 min
What’s in a name? Quite a lot, actually, despite what Shakespeare says.
008: Social Centricity
Oct 20, 2017 • 27 min
Kathleen Starr discusses the importance of the patient’s social context in their healthcare decisions.
007: Medicine in 140 Characters: Digital KOLs
Aug 16, 2017 • 25 min
Channels of influence in pharma have expanded from the traditional offline sphere of publications, trials, conference activities and others to include a vast new dig…
006: Crossing the Finish Line: Factors Driving Patient Adherence to Drug Therapy
Jul 10, 2017 • 24 min
The patient standing at the pharmacy to fill a prescription represents the “final mile” that started in the laboratory. All the science and commercial investment comes down to this one decision poin…
005: The Room Where it Happens: Dealmakers’ Intentions 2017
Jun 20, 2017 • 18 min
At the BIO International Convention, arguably the largest and most important biopharma partnering event of the year with over 16,000 participants, it’s all about getting the deal done. While the …
004: Innovation in Pharma Communications
Jun 14, 2017 • 25 min
According to Leigh Householder, Managing Director of Innovation for inVentiv Health Communications, in an industry where the appetite for innovation and change is strong, but the tolerance for risk is not, the answer lies in an accountable,
003: Payer Power
Apr 3, 2017 • 20 min
The power of the payer in the biopharmaceutical industry has increased dramatically over the past several years, according to Keith Kelly, Managing Director and Head of the Pricing and Market Access Practice of
002: The Impact of AHCA on Pharma
Mar 21, 2017 • 28 min
Introduced on March 6, 2017, if passed the American Health Care Act of 2017 (AHCA) is expected to have an enormous impact on Pharma. The Congressional Budget Office (CBO) on Ma…
001: The Real-World Evidence Revolution
Mar 3, 2017 • 23 min
The passage of the 21st Century Cures Act earlier this year catapulted the concept of “real-world evidence” into the spotlight, with many biopharmaceutical companies wo…